Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management. Paediatr Drugs. 2007;9: 413 418. 358. Matteucci MC, Chinali M, Rinelli G, et al. Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. Clin J Am Soc Nephrol. 2013;8:203 210. 359. Flynn JT, Daniels SR, Hayman LL, et al. Update: ambulatory blood pressure monitoring in children and adolescents: a scienti c statement from the American Heart Association. Hypertension. 2014;63:1116 1135. 360. Ku E, McCulloch CE, Warady BA, et al. Twenty-four-hour ambulatory blood pressure versus clinic blood pressure measurements and risk of adverse outcomes in children with CKD. Clin J Am Soc Nephrol. 2018;13:422 428. 361. Stergiou GS, Karpettas N, Panagiotakos DB, et al. Comparison of of ce, ambulatory and home blood pressure in children and adolescents on the basis of normalcy tables. J Hum Hypertens. 2011;25:218 223. 362. Stergiou GS, Boubouchairopoulou N, Kollias A. Accuracy of automated blood pressure measurement in children: evidence, issues, and perspectives. Hypertension. 2017;69:1000 1006. 363. Wuhl E, Hadtstein C, Mehls O, et al. Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res. 2004;55:492 497. 364. Warady BA, Abraham AG, Schwartz GJ, et al. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the Chronic Kidney Disease in Children (CKiD) cohort. Am J Kidney Dis. 2015;65:878 888. 365. Stergiou G, Stambolliu E, Bountzona I, et al. Home blood pressure monitoring in children and adolescents: systematic review of evidence on clinical utility. Curr Hypertens Rep. 2019;21:64. 366. Dionne JM, Jiang S, Ng D, et al. Ambulatory blood pressure and CKD progression in the CKiD cohort [Abstract FR-PO543]. J Am Soc Nephrol. 2017;28:542. 367. Hanson CS, Gutman T, Craig JC, et al. 